New name, but same old problems for Posimir as FDA hits Durect again

Ben Adams Durect may have changed the name of its post-pain gall bladder surgery drug from "Posidur" to "Posimir" this year, but this has not stopped its run of ...

Langer-backed biotech reboots with $38M, new name and new cancer drug tech

John Carroll Four-year-old biotech Blend Therapeutics, launched with the scientific backing of MIT's Robert Langer and colleagues, is jettisoning its one-time lead drug program ...

It’s Merck vs. Merck as name confusion, complicated by social media, leads to legal showdown

Eric Palmer Merck has won a legal battle over Merck, which in return says it will file a lawsuit against Merck. It sounds confusing, but confusion is the essence of the legal battle ...

The FDA offers a controversial solution to the biosimilars name game

John Carroll The industry has been wrestling for years now over naming the first wave of biosimilars building on the coast of the American drug industry. A lot of companies that develop ...

Sanofi’s finally going to name a new CEO, chairman says

Damian Garde Sanofi will announce its new chief executive by the end of March, the drugmaker's chairman said, ending months of speculation and reported recruitment failure. FierceBiotech ...

Want to claim a name? FDA needs your input on locking down brand monikers

Justin Heifetz Advertising experts have a few tricks up their sleeves when concocting a drug's proprietary name–like Zytiga, Xtandi and Xeljanz–that might thrust the ...

PhIII antibiotic developer gets a new name, new CEO in makeover

John Carroll The New Haven, CT-based biotech Rib-X is undergoing a makeover. The biotech has a new name and is now being run by a new management team drawn in by a new lead investor. ...

What’s In A Name? The Fight Over Biosimilar Nomenclatures

esilverman More than a year after drugmakers began jousting over names for biosimilars, the trade group for generic drugmakers has taken the formal step of filing a citizen’s ...

You Just Won… Lilly Fights Scam Artists Over Use Of Its Name

esilverman You know you have a popular brand when scam artists are using it to bolster their schemes. But Eli Lilly, which says scamsters are using its well-known moniker and ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS